SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., a clinical-stage biotechnology company specializing in cancer therapies, will be present at the Cantor Global Healthcare Conference 2025 and H.C. Wainwright 27th Annual Global Investment Conference in New York. ALX Oncology aims to advance innovative treatments to improve cancer patients’ outcomes.
ALX Oncology to Participate in Upcoming Investor Conferences in September
-
Flamengo and PSG have faced each other three times; check out their record
-
Indonesia Open Footgolf Tournament: Comedian Oki Rengga Admits Addiction, Wants to Become a Professional Athlete
-
Shameful Incident in Punjab! Landlord Rolls Tenant’s Daughter
-
Virgil van Dijk Expresses Desire for Mohamed Salah to Stay at Liverpool
Deixe um comentário